These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 2172387)
21. Evidence for active Epstein-Barr virus infection in patients with persistent, unexplained illnesses: elevated anti-early antigen antibodies. Jones JF; Ray CG; Minnich LL; Hicks MJ; Kibler R; Lucas DO Ann Intern Med; 1985 Jan; 102(1):1-7. PubMed ID: 2578266 [TBL] [Abstract][Full Text] [Related]
22. IFN-gamma mediated pathways in patients with fatigue and chronic active Epstein Barr virus-infection. Bellmann-Weiler R; Schroecksnadel K; Holzer C; Larcher C; Fuchs D; Weiss G J Affect Disord; 2008 May; 108(1-2):171-6. PubMed ID: 17945348 [TBL] [Abstract][Full Text] [Related]
23. Randomized clinical trial to evaluate the efficacy and safety of valganciclovir in a subset of patients with chronic fatigue syndrome. Montoya JG; Kogelnik AM; Bhangoo M; Lunn MR; Flamand L; Merrihew LE; Watt T; Kubo JT; Paik J; Desai M J Med Virol; 2013 Dec; 85(12):2101-9. PubMed ID: 23959519 [TBL] [Abstract][Full Text] [Related]
24. Infectious mononucleosis fifty years after the discovery of the Paul-Bunnell test. Burgio GR; Monafo V Infection; 1983; 11(1):1-5. PubMed ID: 6302006 [TBL] [Abstract][Full Text] [Related]
25. [A case of infectious mononucleosis due to Epstein-Barr virus with suspected reactivation of human herpesvirus 6]. Shizuma T Kansenshogaku Zasshi; 2008 Jan; 82(1):47-50. PubMed ID: 18306680 [TBL] [Abstract][Full Text] [Related]
33. [Chronic fatigue syndrome--study of 51 cases treated at the Second Tokyo National Hospital]. Nishikai M Nihon Rinsho; 1992 Nov; 50(11):2641-7. PubMed ID: 1337560 [TBL] [Abstract][Full Text] [Related]
34. Case control study of chronic fatigue in pediatric patients. Carter BD; Edwards JF; Kronenberger WG; Michalczyk L; Marshall GS Pediatrics; 1995 Feb; 95(2):179-86. PubMed ID: 7838632 [TBL] [Abstract][Full Text] [Related]
35. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis. Nystad TW; Myrmel H J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144 [TBL] [Abstract][Full Text] [Related]
37. Characteristic T cell dysfunction in patients with chronic active Epstein-Barr virus infection (chronic infectious mononucleosis). Tosato G; Straus S; Henle W; Pike SE; Blaese RM J Immunol; 1985 May; 134(5):3082-8. PubMed ID: 2984282 [TBL] [Abstract][Full Text] [Related]
38. Primary and recurrent cytomegalovirus infections have different effects on human herpesvirus-6 antibodies in immunosuppressed organ graft recipients: absence of virus cross-reactivity and evidence for virus interaction. Ward KN; Sheldon MJ; Gray JJ J Med Virol; 1991 Aug; 34(4):258-67. PubMed ID: 1658217 [TBL] [Abstract][Full Text] [Related]
39. Chronic fatigue syndrome. A critical appraisal of the role of Epstein-Barr virus. Koo D West J Med; 1989 May; 150(5):590-6. PubMed ID: 2545048 [TBL] [Abstract][Full Text] [Related]
40. Lessons from a pilot study of transfer factor in chronic fatigue syndrome. De Vinci C; Levine PH; Pizza G; Fudenberg HH; Orens P; Pearson G; Viza D Biotherapy; 1996; 9(1-3):87-90. PubMed ID: 8993764 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]